The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2023

Filed:

May. 28, 2021
Applicants:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Institute for Research IN Biomedicine, Bellinzona, CH;

Inventors:

Peter Kwong, Washington, DC (US);

Michael Gordon Joyce, Washington, DC (US);

Baoshan Zhang, Bethesda, MD (US);

Yongping Yang, Potomac, MD (US);

Peter Collins, Kensington, MD (US);

Ursula Buchholz, Silver Spring, MD (US);

Davide Corti, Bellinzona, CH;

Antonio Lanzavecchia, Bellinzona, CH;

Guillaume Stewart-Jones, Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61K 39/155 (2006.01); A61K 39/39 (2006.01); A61K 48/00 (2006.01); C07K 14/135 (2006.01);
U.S. Cl.
CPC ...
A61K 39/155 (2013.01); A61K 39/39 (2013.01); A61K 48/00 (2013.01); C07K 14/005 (2013.01); C07K 14/135 (2013.01); C07K 2319/70 (2013.01); C07K 2319/73 (2013.01); C12N 2760/18322 (2013.01); C12N 2760/18334 (2013.01); C12N 2760/18522 (2013.01); C12N 2760/18534 (2013.01);
Abstract

Metapneumovirus (MPV) F proteins stabilized in a prefusion conformation, nucleic acid molecules and vectors encoding these proteins, and methods of their use and production are disclosed. In several embodiments, the MPV F proteins and/or nucleic acid molecules can be used to generate an immune response to MPV in a subject. In additional embodiments, the therapeutically effective amount of the MPV F ectodomain trimers and/or nucleic acid molecules can be administered to a subject in a method of treating or preventing MPV infection.


Find Patent Forward Citations

Loading…